0


IDH1和IDH2突变是人类癌症中的朋友和敌人

IDH1 and IDH2 mutations as friends and foes in human cancer
课程网址: http://videolectures.net/nib_molenaar_human_cancer/  
主讲教师: Remco J. Molenaar
开课单位: 阿姆斯特丹大学
开课时间: 2018-05-07
课程语种: 英语
中文简介:
异钇酸脱氢酶IDH在碳水化合物代谢中非常重要,当在癌细胞中发生突变时,代谢途径会发生显著改变。IDH1/2的体细胞突变发生在20%的髓系肿瘤患者中,包括胶质瘤、黑色素瘤、前列腺癌和急性髓系白血病。与IDH1/2野生型癌症患者相比,具有IDH1/2突变的癌症患者生存期相对较长。各种癌症亚型的潜在分子机制也被证明与氧化还原稳态改变和DNA损伤修复减少有关。此外,我们将讨论正在进行的临床试验,其中我们重新利用已经批准的和非专利药物治疗IDH1/2突变癌症。
课程简介: The enzyme isocytrate dehydrogenase IDH is very important in carbohydrate metabolism, and when mutated in cancer cells, the metabolic pathway is drastically altered. Somatic mutations in IDH1/2 occur in 20% of patients with myeloid neoplasms, including glioma, melanoma, prostate cancer and acute myeloid leukemia. Cancer patients with IDH1/2 mutations have a relatively prolonged survival compared with IDH1/2 wild-type counterparts. The underlying molecular mechanism in various subtypes of cancer have been demonstrated to also involve altered redox homeostasis and reduced DNA damage repair. Furthermore, the ongoing clinical trials in which we repurpose already-approved and off-patent drugs for the treatment of IDH1/2-mutated cancers will be discussed.
关 键 词: 异钇酸脱氢酶IDH; 癌细胞; 癌细胞
课程来源: 视频讲座网
数据采集: 2021-12-10:zkj
最后编审: 2021-12-20:liyy
阅读次数: 85